Axogen, Inc. Annual report pursuant to Section 13 and 15(d)

Leases - Narrative (Details) $ in Thousands	Dec. 27, 2023 USD ($)	Oct. 06, 2023 USD ($)	May 09, 2023 USD ($) ft²	Aug. 22, 2022 USD ($) ft²	Jan. 27, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets						$ 15,562	$ 14,369
2023 Commercial Lease With JA-Cole L.P
Lessee, Lease, Description [Line Items]
Size of building space \| ft²			2,500
Operating lease, incremental borrowing rate			13.90%
Operating lease right-of-use assets			$ 98
Operating lease liability			$ 98
2023 Commercial Lease With JA-Cole L.P., Lease No. 2
Lessee, Lease, Description [Line Items]
Operating lease, incremental borrowing rate		14.20%
Operating lease right-of-use assets		$ 138
Operating lease liability		$ 138
Community Blood Center License and Service Agreement, Ninth Amendment
Lessee, Lease, Description [Line Items]
Operating lease, incremental borrowing rate	13.60%
Operating lease right-of-use assets	$ 1,787
Operating lease liability	$ 1,787
2015 Commercial Lease With JA-Cole L.P
Lessee, Lease, Description [Line Items]
Operating lease, incremental borrowing rate				12.80%	11.30%
Operating lease right-of-use assets				$ 221	$ 641
Operating lease liability				$ 221	$ 641
Commercial Lease With JA-Cole L.P, First Amendment
Lessee, Lease, Description [Line Items]
Size of building space \| ft²				2,500
Commercial Lease With JA-Cole L.P
Lessee, Lease, Description [Line Items]
Size of building space \| ft²				5,000